Loading company…
New Line develops bacteriophage feed additives for livestock and agricultural applications.
Founded in 2018, Shandong New Line BIO INC. is based in Weifang, China. It develops and sells bacteriophage products intended to reduce antibiotic reliance and support animal health. In July 2026, it raised an undisclosed amount of Series A funding led by CMB International Asset Management and Addor Capital to upgrade its bacteriophage library and expand overseas.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in